Ca. Labarrere et al., Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection, CURR OPIN C, 16(2), 2001, pp. 110-117
Transplant-associated coronary artery disease (CAD) is the principal limiti
ng factor for the long-term survival of heart trans plant patients. This re
view discusses early risk factors for the subsequent development of transpl
ant-associated CAD. Early risk factors associated with a prothrombogenic mi
crovasculature, such as deposition of microvascular fibrin, depletion of va
scular tissue plasminogen activator, presence of endothelial activation of
the allograft arterial tree, and loss of vascular antithrombin, as well as
changes in circulation (ie, detectable serum cardiac troponin I and elevate
d serum soluble intercellular adhesion molecule-1 levels) are presented and
discussed. New therapies that could improve the status of the allograft mi
crovasculature and may prevent or mitigate the development of transplant-as
sociated CAD are considered. Curr Opin Cardiol 2001, 16:110-117 (C) 2001 Li
ppincott Williams & Wilkins, Inc.